Docetaxel is most often given to patients with metastatic lung cancer. However, patients in this study had cancer that had not spread beyond the lung, but was not treatable by surgery. Although we need to confirm our results, I believe docetaxel should be an acceptable therapy. While the study s results need to be confirmed in a larger, randomized trial, docetaxel may be available as part of a clinical trial in your area. This year, there will be about 164,100 new cases of lung cancer, and about 156,900 people will die of the disease.
Smoking is by far the leading risk factor for lung cancer.
Quitting smoking at any age greatly lowers the risk of getting lung cancer, heart disease, emphysema and bronchitis. The average age of people found to have lung cancer is 60. In order to view the pdf version of the Cancer Advances, you will need Adobe Acrobat installed on your computer. If you do not have this free software please click here to download. We welcome your questions and comments regarding Cancer Advances.